NMN + BHB + Ginsenosides: The '4-Year Younger' Clock Claim, Decoded
A multi-ingredient NMN stack with BHB and ginsenosides was tied to a roughly 4-year drop in the DNAm PhenoAge epigenetic clock. The catch is that the figure came from an uncontrolled pilot of just eight people, and the authors say it does not establish age reversal. The main 42-day trial had about 10 people per arm, was open-label, and found no significant between-group improvements in cardiopulmonary or cognitive outcomes. This article breaks down what the study did show, the conflict-of-interest details, and how to read clock claims on supplement labels.
Two Popular Supplements Shielded Old Rat Hearts. Here's the Catch
A new rat study found that pairing NMN with melatonin helped aged hearts recover from a heart-attack-style injury better than either compound alone. Treated hearts showed improved coronary flow and pressure recovery, along with lower creatine kinase and inflammatory markers. But the work was done on isolated rat hearts, with melatonin delivered in the perfusion fluid and NMN given by injection. That means it says nothing yet about taking supplements as pills or about human benefit. Here is what the researchers did, what they found, and why it is only a first step.
Blood NAD Doesn't Fall With Age. It Tracks Heart Disease Instead
The standard pitch for NAD supplements is that your levels fall as you age, so you need to top them up. A large new Nature Metabolism study of 1,068 adults found that whole-blood NAD does not decline with age in healthy people. It stays stable in men and actually rises in women. What does track with lower NAD is cardiovascular disease and hypertension. The authors stress that this does not prove NAD supplementation treats either condition.